Cargando…
Can Human Embryonic Stem Cell-Derived Stromal Cells Serve a Starting Material for Myoblasts?
A large number of myocytes are necessary to treat intractable muscular disorders such as Duchenne muscular dystrophy with cell-based therapies. However, starting materials for cellular therapy products such as myoblasts, marrow stromal cells, menstrual blood-derived cells, and placenta-derived cells...
Autores principales: | Ando, Yu, Saito, Marie, Machida, Masakazu, Yoshida-Noro, Chikako, Akutsu, Hidenori, Takahashi, Masataka, Toyoda, Masashi, Umezawa, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494578/ https://www.ncbi.nlm.nih.gov/pubmed/28706537 http://dx.doi.org/10.1155/2017/7541734 |
Ejemplares similares
-
Xenogeneic-free defined conditions for derivation and expansion of human embryonic stem cells with mesenchymal stem cells
por: Akutsu, Hidenori, et al.
Publicado: (2015) -
In vivo maturation of human embryonic stem cell-derived teratoma over time
por: Akutsu, Hidenori, et al.
Publicado: (2016) -
Defining Hypo-Methylated Regions of Stem Cell-Specific Promoters in Human iPS Cells Derived from Extra-Embryonic Amnions and Lung Fibroblasts
por: Nishino, Koichiro, et al.
Publicado: (2010) -
DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time
por: Nishino, Koichiro, et al.
Publicado: (2011) -
Research and Development Strategy for Future Embryonic Stem Cell-Based Therapy in Japan
por: Umezawa, Akihiro, et al.
Publicado: (2020)